MYIA
EDIT icon

Mount Yale Investment Advisors’s Editas Medicine EDIT Stock Holding History

Mount Yale Investment Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$44 – 920
2025
Q2 		$44 Buy
+20
New +$33 ﹤0.01% 1479
2018
Q3 		– Sell
-246
Closed -$9K – 953
2018
Q2 		$9K Hold
246
– – ﹤0.01% 875
2018
Q1 		$8K Buy
+246
New +$8.77K ﹤0.01% 874

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mount Yale Investment Advisors's EDIT Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 20 shares — an estimated $44 sold.

Mount Yale Investment Advisors first reported a position in EDIT in Q1 2018 and held it in 3 quarters. The position peaked at $9K in Q2 2018. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 20 Editas Medicine shares in Q3 2025, an estimated $44.
  • Mount Yale Investment Advisors first reported a position in Editas Medicine in Q1 2018 and held it in 3 quarters.
  • Mount Yale Investment Advisors's Editas Medicine position peaked at $9K in Q2 2018.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.